There you go.
SI just announced in the Maxim interview today, that they are resubmitting this quarter for GvHD, and that they have completed assay work, and optimization of potency assays that were in effect for the trials.
MSB 2022 - The road to commercialisation, page-1383
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
0.000(0.00%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.52 | $4.912M | 3.121M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 16401 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 8722 | 7 |
View Market Depth
| Last trade - 14.34pm 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |